GemPharmatech Co., Ltd. (SHA:688046)
China flag China · Delayed Price · Currency is CNY
31.39
-3.11 (-9.01%)
Nov 16, 2026, 4:00 PM EST

GemPharmatech Statistics

Total Valuation

GemPharmatech has a market cap or net worth of CNY 12.84 billion. The enterprise value is 11.95 billion.

Market Cap12.84B
Enterprise Value 11.95B

Important Dates

The last earnings date was Thursday, October 29, 2026.

Earnings Date Oct 29, 2026
Ex-Dividend Date Oct 22, 2026

Share Statistics

GemPharmatech has 409.16 million shares outstanding. The number of shares has increased by 0.23% in one year.

Current Share Class 409.16M
Shares Outstanding 409.16M
Shares Change (YoY) +0.23%
Shares Change (QoQ) -7.95%
Owned by Insiders (%) 0.01%
Owned by Institutions (%) 17.52%
Float 179.31M

Valuation Ratios

The trailing PE ratio is 62.83 and the forward PE ratio is 60.19.

PE Ratio 62.83
Forward PE 60.19
PS Ratio 13.64
PB Ratio 5.52
P/TBV Ratio 5.68
P/FCF Ratio 49.21
P/OCF Ratio 38.68
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 38.59, with an EV/FCF ratio of 45.80.

EV / Earnings 58.92
EV / Sales 12.69
EV / EBITDA 38.59
EV / EBIT 53.46
EV / FCF 45.80

Financial Position

The company has a current ratio of 3.75, with a Debt / Equity ratio of 0.09.

Current Ratio 3.75
Quick Ratio 3.20
Debt / Equity 0.09
Debt / EBITDA 0.67
Debt / FCF 0.80
Interest Coverage 34.00

Financial Efficiency

Return on equity (ROE) is 8.96% and return on invested capital (ROIC) is 13.90%.

Return on Equity (ROE) 8.96%
Return on Assets (ROA) 4.87%
Return on Invested Capital (ROIC) 13.90%
Return on Capital Employed (ROCE) 9.21%
Weighted Average Cost of Capital (WACC) 9.47%
Revenue Per Employee 592,329
Profits Per Employee 127,580
Employee Count1,692
Asset Turnover 0.33
Inventory Turnover 3.87

Taxes

In the past 12 months, GemPharmatech has paid 31.88 million in taxes.

Income Tax 31.88M
Effective Tax Rate 13.58%

Stock Price Statistics

The stock price has increased by +70.78% in the last 52 weeks. The beta is 0.97, so GemPharmatech's price volatility has been similar to the market average.

Beta (5Y) 0.97
52-Week Price Change +70.78%
50-Day Moving Average 32.10
200-Day Moving Average 24.02
Relative Strength Index (RSI) 49.05
Average Volume (20 Days) 8,214,127

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, GemPharmatech had revenue of CNY 941.80 million and earned 202.85 million in profits. Earnings per share was 0.50.

Revenue941.80M
Gross Profit 606.32M
Operating Income 223.56M
Pretax Income 234.73M
Net Income 202.85M
EBITDA 296.62M
EBIT 223.56M
Earnings Per Share (EPS) 0.50
Full Income Statement

Balance Sheet

The company has 1.10 billion in cash and 208.61 million in debt, with a net cash position of 892.30 million or 2.18 per share.

Cash & Cash Equivalents 1.10B
Total Debt 208.61M
Net Cash 892.30M
Net Cash Per Share 2.18
Equity (Book Value) 2.33B
Book Value Per Share 5.69
Working Capital 1.32B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 332.05 million and capital expenditures -71.08 million, giving a free cash flow of 260.97 million.

Operating Cash Flow 332.05M
Capital Expenditures -71.08M
Depreciation & Amortization 73.06M
Net Borrowing -152.23M
Free Cash Flow 260.97M
FCF Per Share 0.64
Full Cash Flow Statement

Margins

Gross margin is 64.38%, with operating and profit margins of 23.74% and 21.54%.

Gross Margin 64.38%
Operating Margin 23.74%
Pretax Margin 24.92%
Profit Margin 21.54%
EBITDA Margin 31.49%
EBIT Margin 23.74%
FCF Margin 27.71%

Dividends & Yields

This stock pays an annual dividend of 0.22, which amounts to a dividend yield of 0.70%.

Dividend Per Share 0.22
Dividend Yield 0.70%
Dividend Growth (YoY) 128.57%
Years of Dividend Growth n/a
Payout Ratio 45.16%
FCF Payout Ratio 50.17%
Buyback Yield -0.23%
Shareholder Yield 0.47%
Earnings Yield 1.59%
FCF Yield 2.03%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside
Graham Formula Value
Graham Formula Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

GemPharmatech has an Altman Z-Score of 10.43 and a Piotroski F-Score of 7.

Altman Z-Score 10.43
Piotroski F-Score 7